GlassScriptPhysician profile
Andrew J Murphy
NPI 1679065510
$6,095.34
in general payments reported to CMS, 2019-2025
15 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $128 · 2023: $450 · 2024: $4,178 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,209 · Travel and Lodging: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,209.09 |
| Travel and Lodging | $1,758.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,895.56 | 2023-2025 | Endurant Iis, Avalus |
| Silk Road Medical, INC. | $1,330.62 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $446.10 | 2023-2025 | (Br5) Peripheral Ivus, Labosys, (Am7) Stellarex |
| Bolton Medical INC | $406.52 | 2024 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $207.36 | 2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Shockwave Medical, INC | $168.75 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $166.91 | 2025 | Ekosonic |
| Allergan, INC. | $127.64 | 2020 | |
| Endologix LLC | $115.70 | 2025 | Torus Stent Graft System, Endocross Device |
| Becton, Dickinson and Company | $115.53 | 2024-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Baxter Healthcare | $33.69 | 2025 | Floseal |
| Chiesi USA, INC. | $22.23 | 2025 | Cleviprex |
| Solventum Corporation | $22.01 | 2025 | V.A.C. Veraflo |
| Enablecv INC. | $21.53 | 2025 | |
| On Target Laboratories, INC | $15.19 | 2025 | Cytalux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.